Patents

Hyperpigmentation Treatment

Los Angeles resident patents a formulation that contains tranexamic acid and niacinamide.

US Patent No. 11,213,473 B1; Christopher Zoumalan of Los Angeles, CA earned a US patent covering his composition to improve hyperpigmentation. It is comprised of tranexamic acid, niacinamide, arbutin, tetrahexyldecyl ascorbate sh-Oligopeptide-1, sh-Polypeptide-22.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters